Annual EBITDA
-$17.06 M
-$8.16 M-91.68%
December 31, 2023
Summary
- As of February 7, 2025, COSM annual EBITDA is -$17.06 million, with the most recent change of -$8.16 million (-91.68%) on December 31, 2023.
- During the last 3 years, COSM annual EBITDA has fallen by -$21.45 million (-488.56%).
- COSM annual EBITDA is now -339.44% below its all-time high of $7.13 million, reached on December 1, 2014.
Performance
COSM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$1.70 M
+$238.20 K+12.31%
September 30, 2024
Summary
- As of February 7, 2025, COSM quarterly EBITDA is -$1.70 million, with the most recent change of +$238.20 thousand (+12.31%) on September 30, 2024.
- Over the past year, COSM quarterly EBITDA has increased by +$11.58 million (+87.22%).
- COSM quarterly EBITDA is now -130.38% below its all-time high of $5.59 million, reached on September 1, 2014.
Performance
COSM Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$18.29 M
+$942.40 K+4.90%
September 30, 2024
Summary
- As of February 7, 2025, COSM TTM EBITDA is -$18.29 million, with the most recent change of +$942.40 thousand (+4.90%) on September 30, 2024.
- Over the past year, COSM TTM EBITDA has dropped by -$1.60 million (-9.61%).
- COSM TTM EBITDA is now -322.45% below its all-time high of $8.22 million, reached on September 1, 2014.
Performance
COSM TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
COSM EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -91.7% | +87.2% | -9.6% |
3 y3 years | -488.6% | +87.2% | -9.6% |
5 y5 years | -678.5% | -179.2% | -960.8% |
COSM EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -347.0% | at low | -238.4% | +87.2% | <-9999.0% | +4.9% |
5 y | 5-year | -488.6% | at low | -179.2% | +87.2% | -484.0% | +4.9% |
alltime | all time | -339.4% | at low | -130.4% | +87.2% | -322.4% | +4.9% |
Cosmos Health EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$1.70 M(-12.3%) | -$18.29 M(-4.9%) |
Jun 2024 | - | -$1.94 M(+40.4%) | -$19.23 M(+8.0%) |
Mar 2024 | - | -$1.38 M(-89.6%) | -$17.81 M(+6.8%) |
Dec 2023 | -$17.06 M(+91.7%) | -$13.28 M(+403.1%) | -$16.69 M(+32.4%) |
Sep 2023 | - | -$2.64 M(+410.7%) | -$12.60 M(+18.8%) |
Jun 2023 | - | -$516.80 K(+106.5%) | -$10.61 M(+2.2%) |
Mar 2023 | - | -$250.30 K(-97.3%) | -$10.38 M(+16.6%) |
Dec 2022 | -$8.90 M(+133.2%) | -$9.19 M(+1318.0%) | -$8.90 M(+8491.9%) |
Sep 2022 | - | -$648.30 K(+126.6%) | -$103.60 K(+13.2%) |
Jun 2022 | - | -$286.10 K(-123.3%) | -$91.50 K(-90.8%) |
Mar 2022 | - | $1.23 M(-410.1%) | -$990.00 K(-74.1%) |
Dec 2021 | -$3.82 M(-186.9%) | - | - |
Dec 2021 | - | -$395.50 K(-37.8%) | -$3.82 M(+32.6%) |
Sep 2021 | - | -$636.20 K(-46.3%) | -$2.88 M(+378.0%) |
Jun 2021 | - | -$1.18 M(-26.0%) | -$602.10 K(-122.1%) |
Mar 2021 | - | -$1.60 M(-394.4%) | $2.73 M(-37.9%) |
Dec 2020 | $4.39 M(-544.2%) | $543.80 K(-66.8%) | $4.39 M(-7.8%) |
Sep 2020 | - | $1.64 M(-23.5%) | $4.76 M(+124.2%) |
Jun 2020 | - | $2.14 M(+3207.1%) | $2.12 M(-304.3%) |
Mar 2020 | - | $64.80 K(-92.9%) | -$1.04 M(+47.6%) |
Dec 2019 | -$988.60 K(-54.9%) | $915.80 K(-191.7%) | -$704.60 K(-91.7%) |
Sep 2019 | - | -$998.90 K(-2.2%) | -$8.48 M(+193.4%) |
Jun 2019 | - | -$1.02 M(-355.3%) | -$2.89 M(+819.5%) |
Mar 2019 | - | $400.10 K(-105.8%) | -$314.30 K(-85.7%) |
Dec 2018 | -$2.19 M(-51.8%) | -$6.86 M(-249.4%) | -$2.19 M(-184.1%) |
Sep 2018 | - | $4.59 M(+195.4%) | $2.61 M(-238.1%) |
Jun 2018 | - | $1.55 M(-205.2%) | -$1.89 M(-54.0%) |
Mar 2018 | - | -$1.48 M(-28.4%) | -$4.10 M(-9.7%) |
Dec 2017 | -$4.54 M(+1080.7%) | -$2.06 M(-2176.6%) | -$4.54 M(+68.1%) |
Sep 2017 | - | $99.30 K(-115.0%) | -$2.70 M(-4.8%) |
Jun 2017 | - | -$662.30 K(-65.5%) | -$2.84 M(+25.5%) |
Mar 2017 | - | -$1.92 M(+767.3%) | -$2.26 M(+488.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2016 | -$384.80 K(-94.2%) | -$221.20 K(+489.9%) | -$384.70 K(-94.1%) |
Sep 2016 | - | -$37.50 K(-55.9%) | -$6.49 M(-0.5%) |
Jun 2016 | - | -$85.10 K(+108.1%) | -$6.52 M(-0.4%) |
Mar 2016 | - | -$40.90 K(-99.4%) | -$6.55 M(-0.6%) |
Dec 2015 | -$6.59 M(-192.5%) | -$6.33 M(+9196.2%) | -$6.59 M(+1230.6%) |
Sep 2015 | - | -$68.10 K(-37.8%) | -$495.40 K(-109.6%) |
Jun 2015 | - | -$109.40 K(+31.0%) | $5.16 M(-18.6%) |
Mar 2015 | - | -$83.50 K(-64.4%) | $6.33 M(-11.1%) |
Dec 2014 | $7.13 M(+2368.2%) | -$234.40 K(-104.2%) | $7.13 M(-13.3%) |
Sep 2014 | - | $5.59 M(+424.1%) | $8.22 M(+221.6%) |
Jun 2014 | - | $1.07 M(+50.6%) | $2.56 M(+76.5%) |
Mar 2014 | - | $707.90 K(-17.9%) | $1.45 M(+111.6%) |
Dec 2013 | $288.70 K(-185.7%) | $861.80 K(-1186.8%) | $684.50 K(-336.1%) |
Sep 2013 | - | -$79.30 K(+88.8%) | -$289.90 K(-13.9%) |
Jul 2013 | -$336.80 K(>+9900.0%) | -$42.00 K(-25.0%) | -$336.70 K(-4.9%) |
Apr 2013 | - | -$56.00 K(-50.3%) | -$354.20 K(+0.9%) |
Jan 2013 | - | -$112.60 K(-10.7%) | -$351.00 K(+19.7%) |
Dec 2012 | -$500.00(-99.8%) | - | - |
Oct 2012 | - | -$126.10 K(+111.9%) | -$293.20 K(-10.3%) |
Jul 2012 | -$326.90 K(+94.1%) | -$59.50 K(+12.7%) | -$326.90 K(-0.5%) |
Apr 2012 | - | -$52.80 K(-3.6%) | -$328.60 K(-9.5%) |
Jan 2012 | - | -$54.80 K(-65.7%) | -$363.00 K(+14.8%) |
Oct 2011 | - | -$159.80 K(+161.1%) | -$316.10 K(+91.8%) |
Jul 2011 | -$168.40 K(-95.6%) | -$61.20 K(-29.8%) | -$164.80 K(-95.7%) |
Apr 2011 | - | -$87.20 K(+1003.8%) | -$3.82 M(+1.8%) |
Jan 2011 | - | -$7900.00(-7.1%) | -$3.76 M(0.0%) |
Oct 2010 | - | -$8500.00(-99.8%) | -$3.76 M(-0.8%) |
Jul 2010 | -$3.79 M(>+9900.0%) | -$3.72 M(>+9900.0%) | -$3.79 M(+5469.6%) |
Apr 2010 | - | -$21.10 K(+167.1%) | -$68.00 K(+45.0%) |
Jan 2010 | - | -$7900.00(-79.7%) | -$46.90 K(+20.3%) |
Oct 2009 | - | -$39.00 K | -$39.00 K |
Jul 2009 | -$4600.00 | - | - |
FAQ
- What is Cosmos Health annual EBITDA?
- What is the all time high annual EBITDA for Cosmos Health?
- What is Cosmos Health annual EBITDA year-on-year change?
- What is Cosmos Health quarterly EBITDA?
- What is the all time high quarterly EBITDA for Cosmos Health?
- What is Cosmos Health quarterly EBITDA year-on-year change?
- What is Cosmos Health TTM EBITDA?
- What is the all time high TTM EBITDA for Cosmos Health?
- What is Cosmos Health TTM EBITDA year-on-year change?
What is Cosmos Health annual EBITDA?
The current annual EBITDA of COSM is -$17.06 M
What is the all time high annual EBITDA for Cosmos Health?
Cosmos Health all-time high annual EBITDA is $7.13 M
What is Cosmos Health annual EBITDA year-on-year change?
Over the past year, COSM annual EBITDA has changed by -$8.16 M (-91.68%)
What is Cosmos Health quarterly EBITDA?
The current quarterly EBITDA of COSM is -$1.70 M
What is the all time high quarterly EBITDA for Cosmos Health?
Cosmos Health all-time high quarterly EBITDA is $5.59 M
What is Cosmos Health quarterly EBITDA year-on-year change?
Over the past year, COSM quarterly EBITDA has changed by +$11.58 M (+87.22%)
What is Cosmos Health TTM EBITDA?
The current TTM EBITDA of COSM is -$18.29 M
What is the all time high TTM EBITDA for Cosmos Health?
Cosmos Health all-time high TTM EBITDA is $8.22 M
What is Cosmos Health TTM EBITDA year-on-year change?
Over the past year, COSM TTM EBITDA has changed by -$1.60 M (-9.61%)